The prognosis for brain cancer has not changed much over the last few decades, but researchers at The University of Kansas Cancer Center are working to change that. Dr. David Akhavan, radiation oncologist and physician-scientist, will share how immunotherapy for brain cancer is the next breakthrough in research. Also joining the conversation will be Matt Anthony, founder of Head for the Cure and a cancer survivor.
